PharVision Advisers’s Telos TLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$58.1K Sell
13,871
-88,693
-86% -$419K 0.59% 82
2025
Q4
$523K Buy
+102,564
New +$640K 0.26% 32

Other funds holding TLS

PharVision Advisers's TLS Position: Q1 2026 in Review

PharVision Advisers reduced its Telos (TLS) stake by 86% in Q1 2026, selling an estimated $419K and leaving 13,871 shares worth $58.1K. The position accounts for 0.59% of the portfolio, ranked #82.

PharVision Advisers first reported a position in TLS in Q4 2025 and has held it in 2 quarters since. The position peaked at $523K in Q4 2025. 160 funds tracked by Wall St. Rank hold TLS as of Q1 2026.

  • PharVision Advisers held 13,871 shares of Telos worth $58.1K as of Q1 2026.
  • PharVision Advisers sold 88,693 Telos shares in Q1 2026, an estimated $419K.
  • Telos made up 0.59% of PharVision Advisers's portfolio in Q1 2026, its #82 holding.
  • PharVision Advisers first reported a position in Telos in Q4 2025 and has held it in 2 quarters since.
  • PharVision Advisers's Telos position peaked at $523K in Q4 2025.
  • 160 funds tracked by Wall St. Rank held Telos as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.